Iovance Biotherapeutics Inc. Common Stock vs Semtech Corporation Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.69 (market cap $6.04B), while Semtech Corporation Common Stock trades at $186.63 (market cap $17.49B). The key difference: Semtech Corporation Common Stock is far larger — about 2.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 4,235,937). Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Semtech Corporation Common Stock for 1 Days on average.
| IOVA | SMTC | |
|---|---|---|
Market Cap | $6.04B | $17.49B |
Volume | 14,805,993 | 4,235,937 |
Sector | Health | Technology |
52-Week High | $14.82 | $197.20 |
52-Week Low | $1.81 | $62.57 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $17.78B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Semtech develops analog and mixed-signal semiconductors and connectivity products. Its technologies are used in communications, data centers, industrial systems, and IoT devices.
Read more on SMTC →